5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
The Medical Aesthetic Devices Market is segmented by Type of Device (Energy-based Aesthetic Device and Non-energy-based Aesthetic Device), Application (Skin Resurfacing and Tightening, Body Contouring and Cellulite Reduction, Hair Removal, Facial Aesthetic Procedures, Breast Augmentation, and Other Applications), End User (Hospitals, Clinics, and Home Settings), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.
Fastest Growing Market:
The global medical aesthetic devices market was valued at USD 11,945.23 million in 2020, and it is estimated to reach a revenue of USD 23,168.32 million in 2026, with a CAGR of 11.08% over the forecast period.
The cosmetic and aesthetic devices manufacturers had to shut down the production and supply units due to the lockdown, that was imposed in the beginning of COVID-19 outbreak, globally. According to a survey by Hamilton Fraser Cosmetic Insurance, conducted in March 2020, with 1,360 cosmetic practitioners in the United Kingdom to assess the impact of the pandemic on cosmetic procedures, stated that 99.78% of practitioners revealed that their practice had been affected during the current pandemic. Additionally, consumers are also looking for online cosmetic home treatments. Thus, the cosmetic brands can exploit this opportunity to renovate their online offerings, to offer e-consultation services, and invest in the right technology, such as chatbots and augmented/virtual reality, as more consumers seek cosmetic advice from the comfort of their home during the pandemic, which reduces the risk of being infected. As per the research article published in Journal of Cutaneous and Aesthetic Surgery (September 2020), airborne contaminants are associated with certain lasers, such as ablative fractional lasers and high-peak-power ultrashort-pulsed lasers, such as nano- and picosecond lasers. Also, devices, such as excimer lamp and skin-tightening devices, have probes that come in close contact with the skin, and the risk of transmission of SARS-CoV2 virus is high. Thus, COVID-19 has highly impacted the medical aesthetic devices market worldwide. However, the situation is gradually improving.
Certain factors that are driving the market growth include increasing obese population, increasing awareness regarding aesthetic procedures, rising adoption of minimally invasive devices, and technological advancement in devices.
The concern of people about their appearance is gradually on a rise, both in the developed and the developing countries. Thus, there is an increase in the number of cosmetic surgeries performed, annually. Although the rate of increase is not much high in developing countries, the fact remains that people are getting more concerned with their appearance, especially with the increasing standard of living.
In Asia, cosmetic surgery has become an accepted practice, and countries, such as China and India, have become Asia's biggest cosmetic surgery market. Also, the growing adoption of minimally invasive and non-invasive aesthetic procedures drives the studied market. With the advent of the internet, information became accessible to everyone and people started becoming more aware of the aesthetic procedures. All these factors together increased the awareness among the masses about the medical aesthetic procedures, which, in turn, increased the sales of medical aesthetic devices, resulting in a huge growth in the market size of medical aesthetic devices.
Additionally, the increasing research and development activities, for the launch of novel products in the market will propel the medical aesthetic devices market. For instance, in June 2020, Cynosure launched the Elite iQ platform, the next generation of the Elite+ Aesthetic Workstation in the United States, European, and Australian markets for laser hair removal and skin revitalization applications. Hence, given the above-mentioned factors and increasing product launches, the market studied is expected to boost over the forecast period.
Medical aesthetic devices refer to all medical devices that are used for various cosmetic procedures, which include plastic surgery, unwanted hair removal, excess fat removal, anti-aging, aesthetic implants, skin tightening, etc., that are used for beautification, correction, and improvement of the body.
Aesthetic procedures include both surgical and non-surgical procedures. The surgical procedure includes liposuction, breast implants, facelifts, radiofrequency, and other related procedures. The non-surgical procedures include chemical peel, non-surgical liposuction, and skin-tightening procedures, among others.
The medical aesthetic devices market is segmented by type of device (energy-based aesthetic device and non-energy-based aesthetic device), application (skin resurfacing and tightening, body contouring and cellulite reduction, hair removal, facial aesthetic procedures, breast augmentation, and other applications), end user (hospitals, clinics, and home settings), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America).The report offers the value (in USD million) for the above segments.
|Type of Device|
|Skin Resurfacing and Tightening|
|Body Contouring and Cellulite Reduction|
|Facial Aesthetic Procedures|
Report scope can be customized per your requirements. Click here.
Breast augmentation, also known as augmentation mammoplasty, is a surgery to increase breast size. It involves placing breast implants under the breast tissue or chest muscles or transferring fat. Breast augmentation procedures have increased over the years. As per a 2019 report by the American Society of Plastic Surgeons (ASPS), the number of breast implant procedures increased considerably in the United States, from 212,500 in 2000 to 299,715 in 2019. Additionally, the increasing product launches and advancements in technologies boosted the growth of the market. For instance, in 2019, Evonik and BellaSeno GmbH entered a long-term agreement for the use of a RESOMER bioresorbable polymer for an innovative breast implant technology. The RESOMER polymer features mechanical properties and a degradation profile that allow the scaffold to safely absorb at a rate that matches the formation of the patient's tissue and is designed to be implanted after breast reconstruction, augmentation, or revision surgery. Thus, owing to the aforementioned factors, the breast augmentation segment is expected to grow significantly over the forecast period.
To understand key trends, Download Sample Report
Medical aesthetic technology has advanced rapidly over the past two decades in North America, especially in the United States. The factors that are expected to impact the studied market growth positively include technological advancement in devices, increasing awareness regarding aesthetic procedures, rising adoption of minimally invasive devices, and increasing obese population in the region. According to the American Society of Plastic Surgeons, 18.1 million cosmetic procedures were recorded in 2019, an increase of 2%, from 2018, which included around 1.8 million cosmetic surgical and 16.3 million cosmetic minimally invasive procedures. Also, the high concentration of major players in the region and subsequent product launches play a vital role in the growth of the studied market in the region. For instance, in June 2020, E.S.I. The novel., a part of Essence Group, launched JOLI360, a new skin rejuvenation solution that can measure three skin parameters: hydration, elasticity, and sebum. Thus, the aforementioned factors are expected to boost the market over the forecast period in North America.
To understand geography trends, Download Sample Report.
The medical aesthetic devices market is moderately competitive and consists many players. Companies, like Abbvie Inc.(Allergan PLC), Alma Lasers Ltd (Sisram Med), Bausch Health Companies Inc. (Solta Medical Inc.), Cutera Inc., El. En. (Asclepion Laser Technologies), Lumenis Inc., Sciton Inc., Syneron Medical Ltd, and Venus Concept, hold a substantial share in the market studied. The major players are involved in strategic alliances, such as acquisitions, collaborations, and research and development activities, to secure their position in the global market. For instance, in May 2020, Abbvie Inc. completed the acquisition of Allergan PLC, thus, expanding its product portfolio in the aesthetic devices market.
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Obese Population
4.2.2 Increasing Awareness Regarding Aesthetic Procedures and Rising Adoption of Minimally Invasive Devices
4.2.3 Technological Advancement in Devices
4.3 Market Restraints
4.3.1 Social Stigma Concerns
4.3.2 Poor Reimbursement Scenario
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 Type of Device
5.1.1 Energy-based Aesthetic Device
220.127.116.11 Laser-based Aesthetic Device
18.104.22.168 Radiofrequency (RF)-based Aesthetic Device
22.214.171.124 Light-based Aesthetic Device
126.96.36.199 Ultrasound Aesthetic Device
5.1.2 Non-energy-based Aesthetic Device
188.8.131.52 Botulinum Toxin
184.108.40.206 Dermal Fillers and Aesthetic Threads
220.127.116.11.1 Facial Implants
18.104.22.168.2 Breast Implants
22.214.171.124.3 Other Implants
126.96.36.199 Other Aesthetic Devices
5.2.1 Skin Resurfacing and Tightening
5.2.2 Body Contouring and Cellulite Reduction
5.2.3 Hair Removal
5.2.4 Facial Aesthetic Procedures
5.2.5 Breast Augmentation
5.2.6 Other Applications
5.3 End User
5.3.3 Home Settings
5.4.1 North America
188.8.131.52 United States (By Type of Device, By Application, and By End User)
184.108.40.206 Canada (By Type of Device, By Application, and By End User)
220.127.116.11 Mexico (By Type of Device, By Application, and By End User)
18.104.22.168 Germany (By Type of Device, By Application, and By End User)
22.214.171.124 United Kingdom (By Type of Device, By Application, and By End User)
126.96.36.199 France (By Type of Device, By Application, and By End User)
188.8.131.52 Italy (By Type of Device, By Application, and By End User)
184.108.40.206 Spain (By Type of Device, By Application, and By End User)
220.127.116.11 Rest of Europe (By Type of Device, By Application, and By End User)
18.104.22.168 China (By Type of Device, By Application, and By End User)
22.214.171.124 Japan (By Type of Device, By Application, and By End User)
126.96.36.199 India (By Type of Device, By Application, and By End User)
188.8.131.52 Australia (By Type of Device, By Application, and By End User)
184.108.40.206 South Korea (By Type of Device, By Application, and By End User)
220.127.116.11 Rest of Asia-Pacific (By Type of Device, By Application, and By End User)
5.4.4 Middle-East and Africa
18.104.22.168 GCC (By Type of Device, By Application, and By End User)
22.214.171.124 South Africa (By Type of Device, By Application, and By End User)
126.96.36.199 Rest of Middle-East and Africa (By Type of Device, By Application, and By End User)
5.4.5 South America
188.8.131.52 Brazil (By Type of Device, By Application, and By End User)
184.108.40.206 Argentina (By Type of Device, By Application, and By End User)
220.127.116.11 Rest of South America (By Type of Device, By Application, and By End User)
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbvie Inc. (Allergan PLC)
6.1.2 Alma Lasers Ltd (Sisram Med)
6.1.3 Bausch Health Companies Inc. (Solta Medical Inc.)
6.1.4 Cutera Inc.
6.1.5 El.En. (Asclepion Laser Technologies)
6.1.7 Lumenis Inc.
6.1.8 Sciton Inc.
6.1.9 Syneron Medical Ltd
6.1.10 Venus Concept
6.1.12 Johnson & Johnson
6.1.13 Dentsply Sirona Inc.
6.1.14 Hologic Inc.
6.1.15 Merz Pharma GmbH & Co. KGaA
6.1.16 Sientra Inc.
6.1.17 Valeant Pharmaceutical International Inc.
6.1.18 Zimmer Biomet Holdings Inc.
6.1.19 Human Med AG
6.1.20 Aerolase Corporation
6.1.21 Bohus Biotech AB
6.1.22 ReCosmo Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments